Future Targeted Healthcare Manufacturing Hub

By 2025 targeted biological medicines will transform the precision of healthcare prescription, improve patient care and quality of life. The current "one-size-fits-all" approach to drug development is being chaIlenged by the growing ability to create stratified and personalised medicines targeted to specific sub-populations and even individuals. The Hub will provide the manufacturing infrastructure and capabilities needed to enable LIK manufacturers to exploit fully medical precision advances, through new technologies, skilled personnel, IP and spin-outs. The Hub and its Spokes will address the manufacturing challenges to ensure that new targeted biological medicines can be developed quickly and manufactured at a cost affordable to society.

Principal Investigator: Professor Nigel Titchener-Hooker & Professor Stephen Morris

Project Staff: Nishma Patel

Collaborators:

University of Warwick

Imperial College London

The University of Manchester

University of Nottingham

Loughborough University

Funder: The Engineering and Physical Sciences Research Council (EPSRC)

Start Date: June 2017

Duration: 3 years

Contact: nishma.patel@ucl.ac.uk; steve.morris@ucl.ac.uk